Life ScienceCompany
Koninklijke DSM M&A Summary
Koninklijke DSM has acquired 27 companies, including 1 in the last 5 years. A total of 3 acquisitions came from private equity firms. It has also divested 16 assets.
Koninklijke DSM’s largest acquisition to date was in 2014, when it acquired DPx Holdings BV for $2.7B. It’s largest disclosed sale occurred in 2022, when it sold Royal DSM - Engineering Materials Business to Advent International for $4.2B. Koninklijke DSM has acquired in 8 different US states, and 13 countries. The Company’s most targeted sectors include life science (34%) and chemicals (26%).
Koninklijke DSM Business Overview
Where is Koninklijke DSM headquartered?
Koninklijke DSM is headquartered in Heerlen, Netherlands.
What is Koninklijke DSM’s revenue?
Koninklijke DSM disclosed revenue of 9,204M EUR for 2021 and 8,106M EUR for 2020.
How many employees does Koninklijke DSM have?
Koninklijke DSM has 21,760 employees.
What sector is Koninklijke DSM in?
Koninklijke DSM is a life science company.
When was Koninklijke DSM founded?
Koninklijke DSM was founded in 1902.
M&A Summary
-
M&A Total Activity43
- M&A Buy Activity27
- M&A Sell Activity16
- Total Sectors Invested 5
- Total Countries Invested 13
- M&A Buy/Sell Connections 23
- M&A Advisors 5